Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 1601 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 51 |
| 1602 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 53 |
| 1603 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 45 |
| 1604 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 months |
| 1605 | Apheresis | Allogeneic | Sezary Syndrome | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 1606 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1607 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 37 |
| 1608 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 30 |
| 1609 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 46 |
| 1610 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 52 |
| 1611 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 51 |
| 1612 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 52 |
| 1613 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 60 |
| 1614 | Apheresis | Autologous | Testicular Cancer | Hematology | 2022 | Standard Therapy | Germany | 48 |
| 1615 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1616 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2022 | Experimental Therapy | Poland | 60,11 |
| 1617 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2022 | Experimental Therapy | Poland | 41,9 |
| 1618 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2022 | Experimental Therapy | Poland | 30,1 |
| 1619 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2022 | Experimental Therapy | Poland | 53 |
| 1620 | Skeletal Muscle | Allogeneic – Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2021 | Experimental Therapy | Poland | 7 |
| 1621 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 7,8 |
| 1622 | Cord Tissue | Allogeneic – Unrelated | Acute Myeloid Leukemia – Transplantation Failure | Hematology | 2021 | Experimental Therapy | Poland | 13,5 |
| 1623 | Cord Tissue | Allogeneic – Unrelated | Ags (Autism + Epilepsy) | Neurology | 2021 | Experimental Therapy | Poland | 13,3 |
| 1624 | Cord Tissue | Allogeneic – Unrelated | Ags (Autism + Epilepsy) | Neurology | 2021 | Experimental Therapy | Romania | 13 |
| 1625 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 74,4 |
| 1626 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 64,11 |
| 1627 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 70,11 |
| 1628 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 59,2 |
| 1629 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 47,9 |
| 1630 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1631 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1632 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 66,8 |
| 1633 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 28,4 |
| 1634 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1635 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1636 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1637 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1638 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1639 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1640 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1641 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1642 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1643 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1644 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 54,11 |
| 1645 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1646 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1647 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1648 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1649 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 55,2 |
| 1650 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1651 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 70,5 |
| 1652 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 54,2 |
| 1653 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 58,11 |
| 1654 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1655 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1656 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 1657 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 62,4 |
| 1658 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 74,6 |
| 1659 | Cord Tissue | Allogeneic – Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4 |
| 1660 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 9,2 |
| 1661 | Cord Tissue | Allogeneic – Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 10 |
| 1662 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,6 |
| 1663 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 15,5 |
| 1664 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | no data |
| 1665 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7,11 |
| 1666 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 6,9 |
| 1667 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,9 |
| 1668 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 12,5 |
| 1669 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 12,1 |
| 1670 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7,5 |
| 1671 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 8,7 |
| 1672 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 11,1 |
| 1673 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 5,3 |
| 1674 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,5 |
| 1675 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 8,11 |
| 1676 | Cord Tissue | Allogeneic – Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 6,4 |
| 1677 | Cord Tissue | Allogeneic – Unrelated | Bone Marrow Transplant Rejection; Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 6,8 |
| 1678 | Cord Tissue | Allogeneic – Unrelated | Cerebellar Ataxia | Neurology | 2021 | Experimental Therapy | Poland | 59 |
| 1679 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 3,1 |
| 1680 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 7,1 |
| 1681 | Cord Tissue | Allogeneic – Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5 |
| 1682 | Cord Tissue | Allogeneic – Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 17 |
| 1683 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6,6 |
| 1684 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6,1 |
| 1685 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 1,9 |
| 1686 | Cord Tissue | Allogeneic – Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 11 |
| 1687 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 7,11 |
| 1688 | Cord Tissue | Allogeneic – Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 12 |
| 1689 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 1,9 |
| 1690 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,9 |
| 1691 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 7,9 |
| 1692 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 1,7 |
| 1693 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
| 1694 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,11 |
| 1695 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 11,4 |
| 1696 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 4,3 |
| 1697 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
| 1698 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 2,11 |
| 1699 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 11,6 |
| 1700 | Cord Tissue | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,1 |